Dehydroepiandrosterone (3f3-hydroxy-5-androsten-17-one, I) sulfate (Ia) has been characterized in the anterior and the posterior parts of the brain of adult male rats. Its level (1.58 ± 0.14 and 4.89 ± 1.06 ng/g, mean ± SD, in anterior and posterior brain, respectively) largely exceeded that of I in brain (0.42 ± 0.10 and 0.12 ± 0.03 ng/g in anterior and posterior brain, respectively) and of Ia in plasma (0.26 ± 0.13 ng/ml). Brain Ia level did not seem to depend on adrenal secretion; it was unchanged after administration of corticotropin or dexamethasone for 3 days, and no meaningful change occurred in brain 15 days after adrenalectomy plus orchiectomy, compared with sham-operated controls. In contrast, stress conditions prevailing 2 days after adrenalectomy plus orchiectomy or after the corresponding sham operation resulted in a significantly increased concentration of Ia in the brain. Changes of Ia level in brain occurred irrespective of changes in corresponding plasma samples. It is proposed that Ia formation or accumulation (or both) in the rat brain depends on in situ mechanisms unrelated to the peripheral endocrine gland system. Dehydroepiandrosterone (3,3hydroxy-5-androsten-17-one, I) sulfate (Ia) is below detection limit in the plasma of most adult mammals (1); the exceptions are man and the highest nonhuman primates (1-3). It is a major secretory product ofhuman adrenals (4-7), and its concentration in adult plasma is larger than that of any other steroid. Although Ia is the main precursor of placental estrogens (8-10) and is occasionally converted into active androgens in peripheral tissues (11,12) was added to 2 ml of plasma or <1 g of tissue, and then 5 ml ofacetone/ethanol (1:1) was added. Tissues were homogenized in acetone/ethanol (1:1) with a Teflon/glass homogenizer and sonicated with a Branson Jl sonifier equipped with a minitip at a 100-W setting for 10 sec. The suspensions were kept at 390C overnight and centrifuged at 1000 x g for 10 min. The supernatant was saved, and the pellet was extracted with 4 ml of methanol/chloroform (1:1) with continuous shaking at room temperature for 30 min. The extract was centrifuged, and the two supernatants were combined and taken to dryness. The residue was dissolved in 4 ml of methanol/chloroform (1:1)/10 mM NaCl and deposited on a Sephadex LH-20 column (10 X 445 mm) equilibrated and developed in the same solvent system (15). The first 50 ml to run off contained unconjugated I, Ia was eluted in the next 75 ml. It was completely separated from free I and from I conjugated to fatty acids (16)
4704The publication costs ofthis article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact.